Chewy Shows Significant Profitability Improvement
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 hours ago
0mins
Should l Buy CHWY?
Source: NASDAQ.COM
- Autoship Program Growth: Chewy's Autoship program accounted for 84% of sales in Q4, up from 80.6% a year ago, which not only locks in customers but also reduces inventory management costs, thereby enhancing overall profitability.
- Strong Advertising Business: Chewy's advertising segment has seen robust growth driven by first-party data and a highly engaged audience, with a significant portion of ad-attributed purchases being Autoship orders, providing advertisers with high returns on investment and further boosting the company's operating margin.
- Healthcare Business Expansion: Chewy expanded its vet clinics from 18 to 47 nationwide following the acquisition of Modern Animal, and this higher-margin healthcare segment offers a new avenue for customer attraction while tightly integrating with its online pharmacy to enhance customer retention.
- Profitability Goals: Chewy's adjusted EBITDA margin increased from 4.8% to 5.7% last year, with management expecting similar expansion this year and a long-term goal of reaching a 10% EBITDA margin, indicating a potential 75% growth in EBITDA even with slow revenue growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CHWY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CHWY
Wall Street analysts forecast CHWY stock price to rise
20 Analyst Rating
17 Buy
3 Hold
0 Sell
Strong Buy
Current: 26.970
Low
42.00
Averages
47.06
High
52.00
Current: 26.970
Low
42.00
Averages
47.06
High
52.00
About CHWY
Chewy, Inc. is an e-commerce business geared toward pet products and services. The Company’s products consist of pet food and treats, pet supplies and pet medications, other pet-health products, and pet services. It serves its customers through its retail websites, and its mobile applications and focuses on delivering customer service, competitive prices, convenience, including Chewy’s Autoship subscription program, and a range of pet food, treats and supplies, and pet healthcare products and services. It partners with approximately 3,200 of the brands in the pet industry, and it creates and offers its own private brands. It owns a number of trademark registrations and applications in the United States and in foreign jurisdictions. These trademarks include American Journey, Blue Box Event, Careplus, Chewy, Chewy.com, Chewy Vet Care, Dr. Lyon’s, Frisco, Goody Box, Onguard, PetMD, PracticeHub, Tiny Tiger, True Acre Farms, Tylee’s, Vibeful, and The Zoo.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Autoship Program Growth: Chewy's Autoship program accounted for 84% of sales in Q4, up from 80.6% a year ago, which not only locks in customers but also reduces inventory management costs, thereby enhancing overall profitability.
- Strong Advertising Business: Chewy's advertising segment has seen robust growth driven by first-party data and a highly engaged audience, with a significant portion of ad-attributed purchases being Autoship orders, providing advertisers with high returns on investment and further boosting the company's operating margin.
- Healthcare Business Expansion: Chewy expanded its vet clinics from 18 to 47 nationwide following the acquisition of Modern Animal, and this higher-margin healthcare segment offers a new avenue for customer attraction while tightly integrating with its online pharmacy to enhance customer retention.
- Profitability Goals: Chewy's adjusted EBITDA margin increased from 4.8% to 5.7% last year, with management expecting similar expansion this year and a long-term goal of reaching a 10% EBITDA margin, indicating a potential 75% growth in EBITDA even with slow revenue growth.
See More
- Autoship Program: Chewy's Autoship service accounted for 84% of sales in Q4, up from 80.6% a year ago, which not only locks in customers but also reduces inventory management costs, thereby enhancing overall profitability.
- Advertising Business Growth: Chewy Ads is experiencing strong growth driven by first-party data and a highly engaged audience, with CEO Sumit Singh noting that a significant portion of ad-attributed purchases comes from Autoship orders, which boosts advertising ROI and further enhances operating margins.
- Healthcare Business Expansion: With the acquisition of Modern Animal, Chewy has added 29 Vet Care clinics, bringing the total to 47, and this high-margin healthcare segment provides a new avenue for customer acquisition while tightly integrating with its online pharmacy to enhance customer retention.
- Profitability Improvement: Despite relatively slow revenue growth in its core business, Chewy's adjusted EBITDA margin increased from 4.8% to 5.7%, with expectations for continued expansion this year and a long-term goal of reaching 10%, indicating a potential 75% EBITDA growth even without revenue increases.
See More
- Autoship Program Growth: Chewy's Autoship service accounted for 84% of sales in Q4, up from 80.6% a year ago, which not only locks in customers but also reduces inventory management costs, thereby enhancing the company's profitability.
- Strong Advertising Business: Chewy Ads is experiencing growth driven by first-party data and a highly engaged audience, with CEO Sumit Singh noting that a significant portion of ad-attributed purchases comes from Autoship orders, providing advertisers with high returns on investment and further boosting the company's overall operating margin.
- Healthcare Business Expansion: As of early April, Chewy had 18 Vet Care clinics and recently added 29 more through the acquisition of Modern Animal, with the healthcare business operating at a higher margin, providing a new avenue to attract customers while tightly integrating with its online pharmacy to enhance customer retention.
- Improving Profitability: Chewy's adjusted EBITDA margin was 5.7% last year, up from 4.8% the previous year, with management expecting continued expansion this year and a long-term goal of reaching a 10% EBITDA margin, indicating a potential 75% growth in EBITDA even without revenue growth.
See More
- Significant Customer Growth: Chewy ended fiscal 2025 with 21.3 million active customers, a 4% increase year-over-year, indicating the company's sustained appeal in the pet product market, particularly in enhancing customer loyalty post-pandemic.
- Autoship Sales Growth: Sales from Chewy's Autoship program rose 11.8% year-over-year to $10.5 billion, accounting for 83.3% of total sales, providing a stable revenue stream and enhancing customer retention.
- Expansion in Healthcare Services: Chewy has increased its number of owned clinics to 18 and plans to acquire Modern Animal, which has 29 clinics, expected to add $125 million in annual sales, further expanding its market share in pet healthcare.
- International Market Opportunities: Chewy began its entry into the Canadian market in 2023, showcasing its potential for international expansion, although its current penetration in international markets remains low, with future sales growth expected through geographic expansion.
See More
- Customer Base Growth: Chewy ended fiscal 2025 with 21.3 million active customers, a 4% increase from the previous year, indicating the company's ability to attract loyal customers post-pandemic, which lays a solid foundation for future product expansion.
- Autoship Sales Increase: Chewy's Autoship customer sales rose 11.8% year-over-year to $10.5 billion, accounting for 83.3% of total sales, which not only provides a stable revenue stream but also enhances customer loyalty and satisfaction.
- Healthcare Service Expansion: Chewy opened 10 new clinics last year, bringing the total to 18, and plans to acquire Modern Animal, which has 29 clinics, expected to add $125 million in annual sales, further solidifying its position in the pet healthcare market.
- International Market Opportunities: Chewy began offerings in Canada in 2023, and despite its low penetration in international markets, this presents significant growth potential, especially against the backdrop of rising global pet spending.
See More
- Market Potential: The U.S. pet market surpassed $150 billion last year and is projected to reach $165 billion this year, positioning Chewy as a key player in essential pet products, which can thrive amid economic uncertainties and attract investor interest.
- Clear Competitive Advantage: Chewy offers a comprehensive shopping experience, including food, toys, online vet consultations, and pet health insurance, enhancing customer loyalty; despite competition from Walmart, its digital presence allows it to stand out in the market.
- Successful Autoship Service: Chewy's Autoship service accounts for over 80% of total sales, providing convenience for customers while ensuring predictable future revenue for the company, further solidifying its market position.
- New Revenue Stream: Chewy launched vet care clinics in 2024, creating a new revenue source that not only adds to income but also introduces the e-commerce platform to pet parents who may not yet be aware of it, driving future growth for the company.
See More











